Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial

Title
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial
Authors
Keywords
Autoimmunity, Immune therapy, Type 1 diabetes
Journal
DIABETOLOGIA
Volume 56, Issue 2, Pages 391-400
Publisher
Springer Nature
Online
2012-10-20
DOI
10.1007/s00125-012-2753-4

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started